title: Can a "center effect" explain the higher frequency of inhibitors for a second-generation recombinant factor VIII product?
authors.affiliation: Julius Centre for Health Sciences and Primary Care, Utrecht University Medical Center, Utrecht, The Netherlands.
authors.forename: H Marijke
authors.initials: HM
authors.lastname: van den Berg
authors.affiliation: Department of Clinical Sciences, Lund University, Malmö, Sweden Pediatric Clinic, Skåne University Hospital, Malmö, Sweden.
authors.forename: Rolf
authors.initials: R
authors.lastname: Ljung
mesh_terms: D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D006268:Health Facilities; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans
chemical_list: C577506:recombinant factor VIII N8; D005169:Factor VIII